(Q53168179)
Statements
Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants. (English)
Büller HR
Halperin JL
Bounameaux H
Prins M
22 November 2007
6
2
227-229
1 reference
1 reference